Related Experiment Video
Updated: Aug 16, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
Positron emission tomography in Dyke-Davidoff-Masson syndrome
K Kulkarni1, M R Sperling, C Intenzo
1Nuclear Medicine Staff, Washington Hospital Center, Washington, DC 20010, USA. kanchan.kulkarni@medstar.net
Abstract:
Dyke-Davidoff-Masson syndrome is clinically characterized by hemiparesis, hemiplegia, seizures, mental retardation, and facial asymmetry secondary to congenital or early childhood vascular insult. A 21-year-old man with Dyke-Davidoff-Masson syndrome presented with uncontrolled seizures. The authors present the magnetic resonance (MR) and positron emission tomography (PET) findings of this syndrome.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
¹³C NMR: Distortionless Enhancement by Polarization Transfer (DEPT)
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
